Reproxalap Ophthalmic Solution (0.25%)
ADX-102-AC-011
Phase 2 small_molecule completed
Quick answer
Reproxalap Ophthalmic Solution (0.25%) for Conjunctivitis, Allergic is a Phase 2 program (small_molecule) at Aldeyra Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aldeyra Therapeutics
- Indication
- Conjunctivitis, Allergic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed